|
|
||||||||
Brief Communications |
Correspondence: 1Corresponding Author: Dott. Luca Aresu, DVM, Dipartimento di Patologia Animale, Università degli Studi di Torino, via L. Da Vinci 44, 10095 Grugliasco (Torino), Italy, e-mail: luca.aresu{at}unito.it
| Abstract |
|---|
|
|
|---|
Key Words: Dirofilaria dogs Leishmania membranoproliferative glomerulonephritis transmission electron microscopy
Membranoproliferative glomerulonephritis (MPGN) is a histologic lesion characterized by intraglomerular hypercellularity (mesangial cells, endothelial cells, and inflammatory cells), matrix expansion, and thickening to the walls of the peripheral capillary loops. Immunocomplex deposits in the capillary walls and within mesangium are seen on electron microscopy. Membranoproliferative glomerulonephritis is usually associated with an immune complex–mediated pathogenesis and may be idiopathic (primary) or secondary to viral, bacterial, and parasitic infections. According to the World Health Organization classification, MPGN is subdivided, based on ultrastructural alterations in the glomerular basement membrane (GBM), as type I (subendothelial deposits), type II (intramembranous dense deposits), and type III.6,7 In MPGN type III, immune deposits are found in the subendothelial and mesangial region, similarly to type I; in addition, numerous subepithelial deposits are present.1,6,7,13,14 This work describes the features of MPGN type III in a dog associated with simultaneous infection with Dirofilaria immitis and Leishmania infantum. To the authors' knowledge, this is the first description of MPGN type III in dogs.
A 9-year-old female German Shepherd dog was referred with a 4-week history of poliuria/polydipsia, anorexia, vomiting, and diarrhea with melena. A hematologic evaluation 3 days earlier had revealed blood urea nitrogen increase and elevated serum creatinine and antibodies to Leishmania spp. (IFAT10) and D. immitis antigens (SNAPa). On clinical examination, the animal was in lateral recumbency with a severely dull and depressed mental state (uremic status). Its body condition score was poor, and it exhibited generalized muscle atrophy, tachypnea (60/min), and tachycardia (170/min). Mucous membranes were dry and a pale-yellowish color while all lymph nodes were subjectively normal to decreased in volume. After blood and urine collection and fine needle aspiration of lymph nodes, the dog was hospitalized. Fluid therapy (lactated Ringers) was infused, and antiemetic and gastro protective therapy (metoclopramide, ranitidine) was initiated. Hematologic data showed elevated serum creatinine (13.7 mg/dl; reference range, 0.5–1.5 mg/dl); a marked increase of blood urea nitrogen (132 mmol/l; reference range, 3.6–10,1 mmol/l); hyperphosphatemia (15.3 mg/dl; reference range, 2.6–6.2 mg/dl); and a marked normochromic, normocytic nonregenerative anemia (red blood cell count 2.710 106/mmc3; reference range, 5.7–8.8 106/mmc3; hemoglobin 6.2 g/dl; reference range, 12.9–18.4 g/dl; hematocrit 17.5 %; reference range, 37.1–57.0 %) compatible with chronic renal failure. Moderate hyperproteinemia (8.1 g/dl; reference range, 5.4–7.5 g/dl), characterized by hyperglobulinemia (ß and
globulin) and moderate hypoalbuminemia (2.3 g/dl; reference range, 2.8–3.5 g/dl) with low albumin-globulin ratio (0.4; reference range, 0.6–1.1), and detection of Leishmania spp. amastigotes in the cytologic lymph node smears confirmed the diagnosis of leishmaniasis. The urine sample was isosthenuric with a specific gravity of 1,014 (reference range, 1,015–1,045), a moderate proteinuria of 298 mg/dl, and a high protein/creatinine ratio of 4.5 (reference number, <0.6). Electrophoretic examination of the proteinuria (sodium dodecyl sulfate polyacrylamide gel electrophoresis) showed a mixed protein content suggestive of lesions within the glomerular and tubulointerstitial compartments. Due to the progression of clinical signs and the very poor prognosis, the dog was euthanized, and a postmortem examination was performed.
At necropsy, samples from all organs were fixed in 10% formalin and paraffin embedded for routine histology. Sections of kidneys were stained with periodic acid–Schiff hematoxylin and Masson's trichrome and phosphotungstic acid hematoxylin. Acid fuchsin orange G (AFOG) stain was used to demonstrate immune deposits and to value the interstitial fibrosis. An immunofluorescent study was performed on frozen sections of renal tissue, using fluorescein-conjugated polyclonal antibodies against the following: dog immunoglobulin G (IgG) (H+L), dog IgA, dog IgM, and dog complement component 3 (C3).b Immunohistochemistry to detect Leishmania antigen was performed on liver, spleen, and kidney sections using a rabbit polyclonal antibody.c The liver was pale and diffusely congested. The kidneys appeared of normal shape and size, and the spleen was increased in volume. Twenty-four filarial worms were found in the right atrium, and 3 adult filariae were found in the lungs.
Total genomic DNA was extracted from frozen kidney tissue using a commercial kitd performed under the conditions suggested by the manufacturer. DNA extract was amplified according to Ferroglio and colleagues5 and Mar and colleagues12 for detection of L. infantum and D. immitis DNA.
Histologically, microfilariae were found throughout the vessels of different organs: liver, lungs, spleen, and kidneys. The most significant lesion observed in the liver was a chronic granulomatous inflammatory reaction, characterized by intralobular hepatic granuloma formation with variable numbers of macrophages. Several amastigotes, immunolabeled with anti-Leishmania antigen, were detected in Kupffer cells of the liver, spleen, and kidneys (Fig. 1). Light microscopy examination of the kidney revealed diffuse enlargement of glomerular tufts and glomerular hypercellularity, attributed primarily to mesangial cell proliferation. Mesangial matrix expansion and sclerosis were particularly severe in some glomeruli, and multiple areas of mesangiolysis were present associated with microaneurisms. The glomerular tufts, in some instances, showed a prominent lobular pattern (Fig. 2). Examination of the tissue stained with periodic acid–Schiff revealed thickening of the glomerular capillary walls and occasional duplication of GBM. By AFOG stains at higher magnification, massive deposits of bright red material were visible in the capillary walls and in the mesangium (Fig. 3). Interstitial inflammatory infiltrates were diffusely distributed in the cortex and were predominantly composed of lymphocytes, macrophages, and plasma cells. Focal tubular atrophy was associated with areas of fibrosis demonstrated by staining with Masson's trichrome and AFOG. Immunofluorescence showed heavy, coarse granular complement C3 deposition along peripheral GBM and in the mesangium and a weaker positive reaction to IgG (Fig. 4). Electron microscopic evaluation of renal tissue revealed a marked endocapillary proliferation (proliferating endothelial and mesangial cells) occluding the capillary lumen. Numerous large subepithelial and occasional mesangial deposits were present. Interposition of mesangial cells between endothelial cells and GBM was also noted. The epithelial foot processes were widely effaced (Fig. 5). Polymerase chain reaction products run on 2% agarose evidenced the band of 302 bp and 145 bp, which respectively confirm the presence of D. immitis and L. infantum DNA in kidney tissues.
|
Membranoproliferative glomerulonephritis is considered to be the most frequent type of glomerulonephritis in dogs.4 According to the human classification, the light microscopy features do not define the possible type of MPGN. The use of electron microscopy permits the identification of the distribution of the deposits inside the mesangium and especially in GBM. In our work, the main ultrastructural findings were mesangial, subendothelial, and subepithelial deposits; these features resemble MPGN type III, according to the World Health Organization. Further investigations to focus the mechanism leading to different sites of deposition of immunocomplexes will be helpful for a better characterization of renal disease in dogs and outcome for target therapies.
| Sources and manufacturers |
|---|
|
|
|---|
a. Idexx Laboratories, Westbrook, ME. ![]()
b. Bethyl Laboratories Inc., Montgomery, AL. ![]()
c. Agrolabo, Scarmagno, Italy. ![]()
d. GenomeEluteTM, Sigma-Aldrich, St. Louis, MO. ![]()
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |